AI assistant
Sending…
aTYR PHARMA INC — Director's Dealing 2022
Jan 10, 2022
34337_dirs_2022-01-10_5ed45b4b-e874-4230-9212-8c81280e854b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2022-01-07
Reporting Person: Shukla Sanjay (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-07 | Common Stock | P | 5000 | $6.7613 | Acquired | 25798 | Direct |
More from aTYR PHARMA INC
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 11
Regulatory Filings
2026
Mar 26
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9